In the 25th Aug 2013 week’s edition of Israel’s good news, the highlights include:
· Two new Israeli devices help unconscious patients to breathe and to be fed intravenously.
· Big increase in numbers of Palestinian Arabs employed by Israelis in Judea and Samaria.
· BBC admits that Israelis are saving Syrian lives.
· Israeli scientists have discovered how to turn inedible plants into food crops.
· Israel has built an accurate forecasting system to help put out forest fires.
· Israel’s natural gas begins to boost the economy.
· Two new archaeological links to the Biblical Jewish presence in the Land of Israel.
Click here for “Going the Extra Mile” (fast-loading, text-only version, no adverts).
Page Down for more details on these and other good news stories from Israel.
ISRAEL’S MEDICAL ACHIEVEMENTS
Patients can breathe easier. Students in the bio-design program of the Hadassah Medical Center in Jerusalem’s Hebrew University have designed a robotic intubation device that guides itself to the lungs. The “GuideIN Tube” prevents accidental insertion of the air tube into the food pipe, which can be fatal.
And in the same vein…. A similar idea – the Sagiv (designed by Hadassah / Hebrew U researchers) helps medical staff insert an IV tube (catheter) into the vein, first time and without pain to the patient. It resolves one of the biggest issues for nurses and paramedics – especially in young children whose veins are very thin.
New Israeli tendon helps athletes spring back into action. (Thanks to Israel21c) Torn knee ligaments no longer need end sports careers. Israeli start-up Tavor has developed an implant called Knee-T-Nol made from a titanium alloy. After surgery, you can walk in 12 hours and total recovery is under three months.
Re-growing cartilage. CartiHeal – Israel’s developer of cartilage regeneration technology – was awarded the distinguished “2012 Incubator Company Excellence Award” from Israel’s Chief Scientist. CartiHeal is running a clinical study in leading European medical centers with very promising results.
Generic alternative for brain tumor treatment. Israel’s Teva has partnered with the US/Israeli firm Perrigo to launch “a high quality, less expensive alternative” to Temodar (temozolomide) for the treatment of adult patients with newly diagnosed glioblastoma multiforme (brain tumor). Teva also had good news about its chemotherapy and prostate cancer treatments.
A glue to stop bleeding. Surgeons will be pleased to be able to seal up vascular operations using Seal-V from Israel’s Sealantis. A spin-off from Israel’s Technion, Seal-V is safer than protein based or synthetic based alternatives. It is highly effective, fast bonding, easy to use and has just received European medical approval.